Shrooms vs acid: which hits harder, lasts longer, and carries more clinical risk?

Most patients I see who come in after a difficult psychedelic experience are genuinely surprised by what happened. They researched the drug, they chose a calm setting, and they still ended up in a crisis. The thing that catches people is not the peak of the trip, it is the tail end, when the substance is still active and the mind is exhausted. With LSD especially, that tail can run six hours longer than anyone expected. That gap between expectation and reality is where most of the clinical problems happen.

What shrooms and acid actually are, chemically

Psilocybin is a prodrug. That means you swallow it and your body does the work. Intestinal alkaline phosphatase and liver phosphatases convert psilocybin into psilocin, which is the compound that actually crosses the blood-brain barrier and produces psychedelic effects. Psilocin is structurally close to serotonin, which is why it fits the 5-HT2A receptor so well.

LSD, lysergic acid diethylamide, is semi-synthetic. Albert Hofmann first synthesised it in 1938 from ergotamine, a compound derived from the ergot fungus that grows on rye. It reaches 5-HT2A receptors just as psilocin does, but it also hits dopamine receptors (D1 and D2) and adrenergic receptors, which contributes to its stronger cardiovascular stimulant effects.

The critical structural difference: LSD is a large, rigid molecule. When it binds to a 5-HT2A receptor, an extracellular loop of the receptor folds over it like a lid, physically preventing it from detaching quickly. A 2017 paper in Cell by Wacker and colleagues visualised this mechanism directly using X-ray crystallography. That is the biochemical reason acid lasts so much longer than shrooms, and no amount of “trip-killing” will reverse it once the molecule is seated.

Onset and duration: how the timelines actually compare

This is where the practical difference hits hardest. Shrooms onset is slower than most people expect, typically 30 to 60 minutes after ingestion, though on a full stomach it can push to 90 minutes. The peak lasts roughly 2 to 3 hours. You are largely back to baseline by hour 5 or 6.

LSD onset is similarly variable: 20 to 90 minutes depending on whether you took it sublingually or swallowed it. But the duration is in a different category. A standard recreational dose of 100 to 150 micrograms will keep you in an active altered state for 8 to 10 hours. The tail, residual stimulation, difficulty sleeping, mild perceptual disturbances, can persist for 2 to 4 hours beyond that.

Which one hits harder? Potency and dose compared

This question needs context. Potency is not just about intensity, it is about the dose required to produce a given effect and how predictable that dose is.

LSD is measurably more potent by weight. A threshold dose is roughly 25 micrograms. A full psychedelic experience typically requires 100 to 150 micrograms. That is measured in millionths of a gram.

Psilocybin doses are measured in grams of dried mushroom, but the actual psilocybin content varies enormously, even within the same species, even between mushrooms from the same batch. The Multidisciplinary Association for Psychedelic Studies (MAPS) and Johns Hopkins research groups standardise doses as pure psilocybin in milligrams for this exact reason. In clinical settings, a moderate dose is 20 to 25 mg of pure psilocybin. Recreationally, 3.5 g of dried Psilocybe cubensis might contain anywhere from 10 to 20 mg of psilocybin, but “might” is doing a lot of work there.

The practical answer: LSD is more reliably intense because street tabs are more standardised than dried mushrooms. Shrooms are harder to dose because the psilocybin concentration is genuinely unpredictable. That inconsistency is a clinical risk in itself. A 2022 Neuropsychopharmacology study comparing direct doses of psilocybin and LSD in 28 volunteers found that at equivalent subjective effect levels, LSD produced more tachycardia (elevated heart rate) while psilocybin produced more nausea and a stronger body experience.

How each drug affects the brain differently

Both drugs hit 5-HT2A serotonin receptors in the prefrontal cortex and thalamus. That much is the same. The thalamus acts as a sensory filter, and when 5-HT2A is activated strongly, that filter opens, which is why sensory information becomes amplified and cross-wired (synesthesia, geometric visuals, altered time perception).

Where they diverge is in secondary receptor activity and downstream effects.

LSD also activates dopamine D2 receptors. This is why acid trips tend to feel more stimulating, more “wired,” and more mentally chattery than psilocybin experiences. The adrenergic receptor activation explains the stronger cardiovascular effects: more pronounced tachycardia, greater pupil dilation, and in some users, a more anxious or hyperaroused baseline tone throughout the trip.

Psilocin’s receptor profile is cleaner, it binds primarily at 5-HT2A with some activity at 5-HT2C and 5-HT1A. The result is typically described as warmer and more emotionally saturated, with less of the cerebral, cognitive intensity that characterises LSD. The body load (nausea, muscle tension, temperature fluctuation) tends to be more prominent with psilocybin.

From a neuroimaging standpoint, both substances increase global functional connectivity and reduce the activity of the default mode network (DMN), the brain’s self-referential processing hub. This DMN suppression is thought to underlie the dissolution of ego boundaries both drugs can produce. Psilocybin’s effect on the DMN has been more extensively studied, partly because it has a shorter window and is easier to manage in scanner environments.

Side effects and physical risks of shrooms vs acid

Cardiovascular effects

LSD carries more cardiovascular risk. That is not contested. The dopamine and adrenergic receptor activity produces real tachycardia, heart rates above 100 beats per minute are common. In people with underlying arrhythmias or undiagnosed cardiac conditions, this matters. The 2022 Neuropsychopharmacology comparison study confirmed LSD increased heart rate significantly more than psilocybin at comparable experiential doses.

Psilocybin does elevate blood pressure modestly. It is not inert cardiovascularly, but the magnitude is lower.

Nausea and gastrointestinal effects

Shrooms win this category for discomfort. The chitin in mushroom cell walls is difficult to digest. Nausea is common in the first 30 to 60 minutes after ingestion and is one of the more reliable adverse effects. Some people manage it by making a tea to filter out the plant material, which also speeds onset by bypassing some of the gastric absorption step.

LSD at standard doses causes minimal nausea. Stomach upset with acid is much less common than with shrooms.

Psychological risks: bad trips and psychosis

Both substances can trigger bad trips. The content tends to differ. Acid bad trips are often characterised by paranoia, racing thoughts, and a terrifying inability to stop thinking, the stimulant quality of LSD that is usually pleasant at lower doses becomes relentless and inescapable. Shroom bad trips tend to be more emotionally raw: grief, fear, confrontation with painful memories, or ego dissolution that feels like dying.

If you want to understand what a difficult psilocybin experience looks like in practice, our detailed breakdown of bad trips on mushrooms covers the clinical picture and what actually helps.

The more serious risk is psychosis induction in people with a personal or family history of schizophrenia or bipolar disorder with psychotic features. Both substances can trigger a first psychotic episode in genetically predisposed individuals. This is not dose-dependent in a simple way, low doses can trigger psychosis in vulnerable people. This risk is not theoretical. I have seen it.

Hallucinogen persisting perception disorder (HPPD): the long-term risk both carry

Hallucinogen persisting perception disorder (HPPD) is a condition in which perceptual disturbances from a psychedelic experience, visual snow, geometric patterns, afterimages, halos around objects, persist after the drug is gone. It is listed in DSM-5.

Both LSD and psilocybin can cause HPPD, but LSD appears more commonly linked to it in the clinical literature. This may reflect prevalence of use rather than a true pharmacological difference. The mechanism is not fully understood. One working theory involves lasting changes in cortical excitability, possibly involving GABA-A interneuron suppression, which normally keeps visual processing in check.

HPPD ranges from mild and easily ignored to severely disabling. Some patients describe symptoms that have persisted for years. There is no established pharmacological cure. Case reports support some benefit from clonazepam and, in refractory cases, lamotrigine, but evidence quality is low. The most reliable intervention is stopping all hallucinogen use.

Addiction potential: can you get hooked on shrooms or acid?

Physical dependence does not develop with either substance. You will not go into withdrawal. You will not wake up the next morning needing another dose to feel normal. The receptor downregulation that makes redosing unrewarding also makes classical addiction physiology nearly impossible with these compounds.

That said, psychological dependence is real and worth taking seriously. Some people return to psychedelics repeatedly as a way to escape difficult emotions, to chase a particular insight, or because baseline reality feels grey and flat compared to the altered state. That pattern meets DSM-5 criteria for a substance use disorder, even without physical dependence, if it causes significant impairment or distress.

LSD’s longer duration and stimulant properties also make it more prone to anxious re-use, some users chase a more manageable experience after a difficult trip, which can develop into a problematic pattern.

For a closer look at how psilocybin and LSD compare specifically in terms of dependence risk and classification, the shrooms vs LSD page covers that comparison in more depth.

Combining shrooms or acid with other substances

This is where clinical risk increases substantially.

Shrooms and alcohol together reduce the psychedelic intensity of the mushrooms while adding its own depressant effects, and often result in more confusion, vomiting, and distress. The combination also makes it harder to assess clinical status if someone deteriorates. You can read more about the specific risks of mixing mushrooms and alcohol and what that combination actually does.

LSD combined with stimulants (amphetamines, MDMA, cocaine) dramatically increases cardiovascular risk. Combining it with lithium, which is used to treat bipolar disorder, is associated with seizures and should be considered an absolute contraindication.

Both substances combined with antidepressants that are selective serotonin reuptake inhibitors (SSRIs) can either blunt the trip significantly (chronic SSRI use desensitises 5-HT2A) or, in theory, contribute to serotonin syndrome, though clinical cases of serotonin syndrome from psychedelic-SSRI combinations alone are rare.

Legal status and what that means for clinical risk

Both psilocybin and LSD are Schedule I substances under the US Controlled Substances Act and under the UN Convention on Psychotropic Substances, meaning they have no accepted medical use under current federal law (though Oregon and Colorado have created state-level frameworks for supervised psilocybin use).

In Thailand, both are Category 1 narcotics under the Narcotics Act B.E. 2522, carrying severe criminal penalties.

The legal status has a direct clinical consequence: people who use these substances recreationally do so with no quality control, no dose verification, and no clinical supervision. Street LSD tabs vary enormously, what is sold as 100 micrograms may contain half that or double. Worse, some street “acid” is not LSD at all but NBOMe compounds (25I-NBOMe, 25C-NBOMe), which are not serotonergic in the same way and have caused deaths at doses that would be safe with genuine LSD. Shrooms at least have the advantage of being identifiable, though misidentification of species remains a genuine poisoning risk.

Psychedelic use disorder is real, even if it looks different from alcohol or opioid dependence. The DSM-5 pattern to watch for includes using more than intended, repeated failed attempts to cut back, continued use despite psychological consequences (anxiety that persists between trips, worsening depression, HPPD symptoms), and use that is displacing work, relationships, or functioning. If someone is planning their month around trips, using psychedelics to cope with stress or trauma rather than addressing it, or finding that baseline reality feels permanently worse than it did before they started, those are clinical signals.

At Phuket Island Rehab, we work with people for whom psychedelic use has crossed from experimentation into a pattern that is causing real harm. That includes people dealing with HPPD, those who have had a psychosis-triggering experience and need stabilisation, and those using hallucinogens as a coping mechanism for underlying trauma or mood disorders. Treatment is individualised, not one-size-fits-all, and the work is done without judgment about how someone got here.

From a practical standpoint: LSD is harder to end once started, more cardiovascularly stimulating, and more prone to cross-contamination with dangerous substitutes like NBOMe compounds. Shrooms are shorter-acting but dose-unpredictable and more likely to produce nausea and emotionally confronting experiences. Combining either substance with lithium, MAOIs, or stimulants substantially elevates risk. If someone has a personal or family history of psychosis or bipolar disorder with psychotic features, both substances should be avoided entirely.

As John A. Smith of Phuket Island Rehab puts it: “The patients who end up in the most trouble are not the ones who had a bad trip and knew it was bad. They are the ones who had a difficult experience, told themselves it was growth, went back for more, and by the third or fourth time they were trying to process something with a substance that was making it worse.”

Which is stronger, shrooms or acid?

LSD is more potent by weight and generally produces a more intense, longer-lasting experience than psilocybin at standard recreational doses. A threshold LSD dose is around 25 micrograms, while psilocybin effects require milligrams of the active compound. However, shrooms are harder to dose accurately because psilocybin content varies significantly between batches, meaning an unexpectedly strong shroom experience is common. At equivalent subjective intensity levels, the 2022 Neuropsychopharmacology comparative study found the experiences broadly similar, with LSD producing more tachycardia and psilocybin producing more nausea.

How long does an acid trip last compared to a shroom trip?

An acid trip typically lasts 8 to 12 hours, with a residual stimulant tail of another 2 to 4 hours that makes sleep difficult. A shroom trip is usually complete within 4 to 6 hours. The difference comes down to a receptor-trapping mechanism: LSD is physically held inside the 5-HT2A receptor by a protein loop that folds over it, preventing the drug from detaching and being metabolised as quickly as psilocin.

Can shrooms or acid cause psychosis?

Yes, both can trigger a first psychotic episode in people with a personal or family history of schizophrenia or bipolar disorder with psychotic features. This risk is not purely dose-dependent, low doses in genetically predisposed individuals have triggered psychosis. This is why a psychiatric history screen is included in clinical psilocybin research protocols as an exclusion criterion. Anyone with a family history of psychosis should treat both substances as contraindicated.

What is HPPD and which drug causes it more?

Hallucinogen persisting perception disorder (HPPD) is a DSM-5 diagnosis in which visual disturbances from a psychedelic experience, such as visual snow, geometric patterns, or afterimages, persist after the drug has worn off. Both LSD and psilocybin are associated with HPPD, though LSD appears more frequently in case reports. Whether that reflects a true pharmacological difference or simply greater prevalence of LSD use in the populations studied is not fully clear. The most effective management is stopping all hallucinogen use.

Is acid or shrooms more addictive?

Neither is physically addictive in the way alcohol, opioids, or benzodiazepines are. The receptor downregulation that makes redosing unrewarding within days rules out the tolerance-and-withdrawal cycle that drives physical dependence. Psychological dependence is possible with both, and meets DSM-5 criteria for a substance use disorder if it causes significant impairment. LSD’s stimulant properties and longer duration may make it slightly more prone to anxious re-use patterns, but the difference is not dramatic.

What happens if you mix acid and shrooms?

Taking LSD and psilocybin together, sometimes called “candy flipping with mushrooms” or a “hippie flip,” produces effects that are largely unpredictable because both hit the same 5-HT2A receptors simultaneously and the total dose is difficult to control. The duration will be dominated by LSD, meaning the combined experience can last 10 to 14 hours. The cardiovascular risk increases, and the psychological intensity can exceed what either drug would produce alone. From a clinical standpoint, this combination substantially increases the risk of a crisis requiring emergency intervention.

Are there dangerous substances sold as acid that aren’t LSD?

Yes. NBOMe compounds, particularly 25I-NBOMe and 25C-NBOMe, are sold as LSD tabs but are structurally unrelated to LSD and have caused deaths. They are more toxic at lower doses than genuine LSD and have a different pharmacological profile. An Ehrlich reagent test (legally available as a harm reduction tool) will turn purple with genuine LSD and will not react with NBOMe compounds. This is the single most important safety check for anyone who comes into contact with street “acid.”